APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.

MLA

Tran, Kristine M., et al. “APOE Christchurch Enhances a Disease-Associated Microglial Response to Plaque but Suppresses Response to Tau Pathology.” Molecular Neurodegeneration, vol. 20, no. 1, Jan. 2025, p. 9. EBSCOhost, https://doi.org/10.1186/s13024-024-00793-x.

APA

Tran, K. M., Kwang, N. E., Butler, C. A., Gomez-Arboledas, A., Kawauchi, S., Mar, C., Chao, D., Barahona, R. A., Da Cunha, C., Tsourmas, K. I., Shi, Z., Wang, S., Collins, S., Walker, A., Shi, K.-X., Alcantara, J. A., Neumann, J., Duong, D. M., Seyfried, N. T., … Green, K. N. (2025). APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Molecular Neurodegeneration, 20(1), 9. https://doi.org/10.1186/s13024-024-00793-x

Chicago

Tran, Kristine M, Nellie E Kwang, Claire A Butler, Angela Gomez-Arboledas, Shimako Kawauchi, Cassandra Mar, Donna Chao, et al. 2025. “APOE Christchurch Enhances a Disease-Associated Microglial Response to Plaque but Suppresses Response to Tau Pathology.” Molecular Neurodegeneration 20 (1): 9. doi:10.1186/s13024-024-00793-x.